Abstract A061: A novel genetically engineered mouse model of Myc-driven pancreatic cancer recapitulates phenotypic heterogeneity, metastasis, and therapy resistance seen in clinical populations

Isabel A. English(Oregon Health & Science University), Rosalie C. Sears(Oregon Health & Science University), Terry K. Morgan(Oregon Health & Science University), Motoyuki Tsuda(Oregon Health & Science University), Ashley Kiemen(Johns Hopkins University), Michael B. Heskett(Oregon Health & Science University), Lisa M. Coussens(Oregon Health & Science University), Patrick J. Worth(Oregon Health & Science University), Carl Pelz(Oregon Health & Science University), Laura D. Wood(Johns Hopkins University), Jackie L. Phipps(Oregon Health & Science University), Paul T. Spellman(Oregon Health & Science University), Brittany L. Allen-Petersen(Purdue University West Lafayette), Meghan M. Joly(UL Research Institutes), Mary C. Thoma(Oregon Health & Science University), Jenny Eng(Oregon Health & Science University), Shamilene Sivagnanam(Oregon Health & Science University), Vidhi M. Shah(Oregon Health & Science University), Ellen M. Langer(Oregon Health & Science University), Courtney B. Betts(Oregon Health & Science University), Xiaoyan Wang(Institute of Basic Medical Sciences of the Chinese Academy of Medical Sciences), Jennifer M. Chu(Oregon Health & Science University), Colin J. Daniel(Oregon Health & Science University), Amy Farrell(Northeastern University)
Cancer Research
January 16, 2024
Cited by 0


Related Papers